中关村(000931.SZ)：下属公司北京华素盐酸曲马多片通过一致性评价

Core Viewpoint - Beijing Huasu Pharmaceutical Co., Ltd., a subsidiary of Zhongguancun (000931.SZ), has received approval from the National Medical Products Administration for its drug "Tramadol Hydrochloride Tablets" (specification: 50mg), which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The approval signifies a key milestone for Beijing Huasu in the pharmaceutical market [1] - The drug "Tramadol Hydrochloride Tablets" is now positioned to compete effectively in the generic drug sector [1] - This development may enhance the company's revenue potential and market share in the pain management segment [1]